• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Grants
    • Partners
    • NCSG Bylaws
JOIN NOW
✕
Categories
  • Alcoholic Hepatitis
Tags
  • Alcoholic Hepatitis
Study title A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM)
Disease or condition Alcoholic Hepatitis
Study type Intervention (Clinical Trial)
Intervention/treatment DUR-928 30 mg, DUR-928 90 mg, or Placebo+Standard of Care (SOC)
Phase 2b
Study site Carolinas Medical Center, Center for Liver Disease & Transplant (Atrium Health)
Study location Charlotte, NC
Principal investigator name and email Mark Russo, MD
Study coordinator name and email Marybeth Schwallie@atriumhealth.org
Phone contact 704-355-7608
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04563026

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN NOW